Oxford Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Oxford Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11	Closed	-$66K	–	1431
2019 Q4	$66K	Buy	+11	New	+$104K	﹤0.01%	1649
2019 Q1	–	Sell	-37	Closed	-$558K	–	2067
2018 Q4	$558K	Buy	37 +8	+28%	+$188K	0.01%	1151
2018 Q3	$1.11M	Buy	29 +19	+190%	+$626K	0.02%	959
2018 Q2	$384K	Buy	+10	New	+$380K	0.01%	1431

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Oxford Asset Management's TTOO Position: Q1 2020 in Review

Oxford Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2020, closing a stake of 11 shares — an estimated $66K sold.

Oxford Asset Management first reported a position in TTOO in Q2 2018 and held it in 4 quarters. The position peaked at $1.11M in Q3 2018. 39 funds tracked by Wall St. Rank hold TTOO as of Q1 2020.

Oxford Asset Management reported no remaining T2 Biosystems, Inc position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 11 T2 Biosystems, Inc shares in Q1 2020, an estimated $66K.
Oxford Asset Management first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 4 quarters.
Oxford Asset Management's T2 Biosystems, Inc position peaked at $1.11M in Q3 2018.
39 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.